Stay updated on CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The revision number in the footer changes from v3.7.0 to v3.7.1 while the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-13T08:13:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record page is replaced by a 403 Forbidden message, with a Home link.
    Difference
    0.5%
    Check dated 2026-10-06T08:29:22.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error screen with a minimal header and a Home link, replacing the study details. It indicates restricted access to the record rather than a content update to the study information.
    Difference
    18%
    Check dated 2026-09-22T07:00:11.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a systems update to the page template rather than a change to study data.
    Difference
    0.0%
    Check dated 2026-08-31T23:01:17.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.6.4 to v3.6.5, indicating a small update to the study record.
    Difference
    0.0%
    Check dated 2026-08-10T12:32:33.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, reflecting a minor update to the page system. No study content or results were changed.
    Difference
    0.0%
    Check dated 2026-07-27T06:19:05.000Z thumbnail image

Stay in the know with updates to CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.